Dual Sofosbuvir/Daclatasvir Therapy in Adolescent Patients With Chronic Hepatitis C Infection-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dual Sofosbuvir/Daclatasvir Therapy in Adolescent Patients With Chronic Hepatitis C Infection

Published:2018-07 Issue:1 Volume:67 Page:86-89
ISSN:0277-2116
Container-title:Journal of Pediatric Gastroenterology and Nutrition
language:en
Short-container-title:Journal of Pediatric Gastroenterology and Nutrition

Author:

Yakoot Mostafa,El-Shabrawi Mortada H.,AbdElgawad Manal M.,Mahfouz Aml A.,Helmy Sherine,Abdo Alaa M.,El-Khayat Hisham R.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Pediatrics, Perinatology, and Child Health

Reference6 articles.

1. Treatment of Chronic Hepatitis C Virus Infection in Children: A Position Paper by the Hepatology Committee of European Society of Paediatric Gastroenterology, Hepatology and Nutrition

2. EASL Recommendations on Treatment of Hepatitis C 2016

3. Shortened 8 Weeks Course of Dual Sofosbuvir/Daclatasvir Therapy in Adolescent Patients, With Chronic Hepatitis C Infection

4. A pilot study for safety and efficacy of 12 weeks sofosbuvir plus daclatasvir with or without ribavirin in egyptian adolescents with chronic hepatitis C virus Infection

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ESPGHAN recommendations on treatment of chronic hepatitis C virus infection in adolescents and children including those living in resource‐limited settings;Journal of Pediatric Gastroenterology and Nutrition;2024-02-18

2. Efficacy and safety of DAA in children and adolescents with chronic HCV infection: A systematic review and meta‐analysis;Liver International;2024-01-31

3. National viral hepatitis control program in India: Call for update;Journal of Family Medicine and Primary Care;2023-09

4. Hepatitis during childhood;Comprehensive Guide to Hepatitis Advances;2023

5. The ameliorating role of sofosbuvir and daclatasvir on thioacetamide-induced kidney injury in adult albino rats;Anatomy & Cell Biology;2022-12-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3